The most important financial indicators for the company Mis Pharm Research S.r.l. - Unique Identification Number 47993490:
sales in 2024 was
197.123
euro, registering a net profit of
122.745
euro and having an average number of
1
employees.
Firma isi desfasoara activitatea in domeniul Cercetare-dezvoltare in alte stiinte naturale si inginerie having the NACE code 7219.
Sales, Profit, Employees, Debts, Capitals, Financial Results -
Mis Pharm Research S.r.l.
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
-
-
-
-
-
-
-
-
18.559
197.123
Total Income - EUR
-
-
-
-
-
-
-
-
18.650
199.225
Total Expenses - EUR
-
-
-
-
-
-
-
-
7.029
74.548
Gross Profit/Loss - EUR
-
-
-
-
-
-
-
-
11.620
124.677
Net Profit/Loss - EUR
-
-
-
-
-
-
-
-
11.438
122.745
Employees
-
-
-
-
-
-
-
-
1
1
Tabelul prezinta cei mai importanti indicatori ai firmei din Contul de Profit si Pierderi pentru ultimii 10 ani de activitate asa cum se regasesc la Ministerul de Finante. Datele ofera evolutia firmei in aceasta perioada privind cresterile si eventual descresterile inregistrate.
In the last year of activity, the sales increased by 114.7%, from 18.559 euro in the year 2023, to 197.123 euro in 2024.
The Net Profit increased by 66.166 euro, from 11.438 euro in 2023, to 122.745 in the last year.
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Mis Pharm Research S.r.l. - CUI 47993490
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
-
-
-
-
-
-
-
-
974
4.411
Current Assets
-
-
-
-
-
-
-
-
11.358
123.465
Inventories
-
-
-
-
-
-
-
-
0
0
Receivables
-
-
-
-
-
-
-
-
9.740
94.711
Cash
-
-
-
-
-
-
-
-
1.618
28.754
Shareholders Funds
-
-
-
-
-
-
-
-
11.479
122.985
Social Capital
-
-
-
-
-
-
-
-
40
200
Debts
-
-
-
-
-
-
-
-
853
5.255
Income in Advance
-
-
-
-
-
-
-
-
0
0
Exchange rate - RON
1
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"7219 - 7219"
CAEN Financial Year
7219
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
123.465 euro in 2024 which includes Inventories of
0 euro, Receivables of
94.711 euro and cash availability of
28.754 euro.
The company's Equity was valued at
122.985 euro, while total Liabilities amounted to
5.255 euro.
Equity increased by 66.206 euro, from 11.479 euro in 2023, to 122.985 in 2024.
Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Mis Pharm Research S.r.l.